OverviewChartTechnicalNewsTraderScreen

Pulmatrix Inc/  US74584P3010  /

NASDAQ
2024-04-16  8:04:47 PM Chg. +0.0499 Volume Bid8:42:15 PM Ask8:42:15 PM High Low
2.1399USD +2.39% 5,815
Turnover: 10,585.6141		 2.0900Bid Size: 200 2.1400Ask Size: 100 2.1900 2.0800
GlobeNewswire 2023-12-01 Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
GlobeNewswire 2023-09-05 Invivyd Appoints William Duke as Chief Financial Officer
GlobeNewswire 2021-08-09 Voyager Therapeutics Transforms Pipeline and Increases Investment in Next-Generation TRACER™ AAV Cap...
GlobeNewswire 2021-05-19 Voyager Therapeutics Announces Strategic Shift and Leadership Transitions
GlobeNewswire 2019-11-06 Kaleido Biosciences Appoints William Duke as Chief Financial Officer
GlobeNewswire 2019-01-09 Global Idiopathic Pulmonary Fibrosis Pipeline Insight Report 2018: Detailed Analysis of 65+ Products...
GlobeNewswire 2018-09-11 Vectura Group plc: Interim Results
GlobeNewswire 2018-08-10 Novel Drugs and Smart Devices for Respiratory Disorders, 2030 - Focus on Asthma, COPD and Cystic Fib...
GlobeNewswire 2018-06-21 Bioavailability Enhancement Technologies and Services Market, 2030
GlobeNewswire 2018-06-13 Harvard Bioscience Subsidiary Data Sciences International Launches Inhalation Exposure System
GlobeNewswire 2018-03-21 Vectura Group plc: 2017 Preliminary Results - Performance in-line with expectations, with strong in-...
GlobeNewswire 2018-03-13 World Novel Drugs and Smart Devices for Respiratory Disorders Market, 2030
GlobeNewswire 2017-09-19 CEO Robert Clarke Discusses Positive Developments from Partnerships Obtained within the Past Few Mon...
GlobeNewswire 2017-07-04 Global Cystic Fibrosis Strategic Business Report 2017 - Annual Estimates and Forecasts 2014-2022